Shares of Health Care sector company BioNTech SE moved -1.7% today, and are now trading at a price of $118.85. The large-cap stock's daily volume was 180,206 compared to its average volume of 599,945. The S&P 500 index returned a 0.0% performance.
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is based in Mainz and has 4,530 full time employees. Its market capitalization is $28,642,136,064.
15 analysts are following BioNTech SE and have set target prices ranging from $139.97 to $259.93 per share. On average, they have given the company a rating of buy. At today's prices, BNTX is trading -37.66% away from its average analyst target price of $190.65 per share.
Over the last year, BNTX shares have gone down by -16.6%, which represents a difference of -13.0% when compared to the S&P 500. The stock's 52 week high is $188.99 per share and its 52 week low is $117.08. With average free cash flows of $3,395,315,750.0 that have been growing at an average rate of 165.9% over the last four years, BioNTech SE declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-12-31 | 13,577,400 | -363,300 | 13,214,100 | 1696.13 |
| 2021-12-31 | 889,700 | -154,000 | 735,700 | 843.73 |
| 2020-12-31 | -13,474 | -85,446 | -98,920 | 63.31 |
| 2019-12-31 | -198,537 | -71,080 | -269,617 | n/a |
